Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Buch

Showing results (11-20 of 204) with videos related to

Pageof 21
Sort By:
Expert Opinion on Biological Therapy|March 22, 2018
GP2015 as a promising therapy for rheumatoid arthritisJohn Fitton, Alessandro Giollo, Maya H Buch
Ophthalmology|December 6, 2001
Prevalence and causes of visual impairment according to World Health Organization and United States criteria in an aged, urban Scandinavian population: the Copenhagen City Eye StudyH Buch, T Vinding, N V Nielsen
Clinical and Experimental Rheumatology|August 28, 2018
Can switching to abatacept therapy in patients with rheumatoid arthritis on background methotrexate reverse TNF-inhibitor-induced antinuclear autoantibody/double-stranded DNA autoantibody conversion? An analysis of the AMPLE and ATTEST trialsMaya H Buch, Alyssa Johnsen, Michael Schiff
Expert Opinion on Drug Safety|June 7, 2018
Cardiovascular outcomes of patients with rheumatoid arthritis prescribed disease modifying anti-rheumatic drugs: a reviewAlessandro Giollo, Lesley-Anne Bissell, Maya H Buch
Autoimmunity Reviews|November 1, 2011
To switch or not to switch after a poor response to a TNFα blocker? It is not only a matter of ACR20 OR ACR50Maya H Buch, Andrea Rubbert-Roth, Gianfranco Ferraccioli
Acta Ophthalmologica Scandinavica|August 27, 1999
Pachometry before and after vitrectomy with silicone oil injectionH Buch, N V Nielsen, J U Prause
Nature Reviews. Rheumatology|June 2, 2017
Biologics registers in RA: methodological aspects, current role and future applicationsElena Nikiphorou, Maya H Buch, Kimme L Hyrich
Arthritis Research & Therapy|November 26, 2008
Abatacept in the treatment of rheumatoid arthritisMaya H Buch, Edward M Vital, Paul Emery
Therapeutic Advances in Cardiovascular Disease|February 10, 2011
Antiplatelet therapy and vascular disease: an updateMamta H Buch, Bernard D Prendergast, Robert F Storey
Nature Reviews. Rheumatology|February 6, 2013
Creative trial design in RA: optimizing patient outcomesMaya H Buch, Sue Pavitt, Mahesh Parmar, et al.
Pageof 21

Showing results (11-20 of 204) with videos related to

Sort By:
Pageof 21
Expert Opinion on Biological Therapy|March 22, 2018
GP2015 as a promising therapy for rheumatoid arthritisJohn Fitton, Alessandro Giollo, Maya H Buch
Ophthalmology|December 6, 2001
Prevalence and causes of visual impairment according to World Health Organization and United States criteria in an aged, urban Scandinavian population: the Copenhagen City Eye StudyH Buch, T Vinding, N V Nielsen
Clinical and Experimental Rheumatology|August 28, 2018
Can switching to abatacept therapy in patients with rheumatoid arthritis on background methotrexate reverse TNF-inhibitor-induced antinuclear autoantibody/double-stranded DNA autoantibody conversion? An analysis of the AMPLE and ATTEST trialsMaya H Buch, Alyssa Johnsen, Michael Schiff
Expert Opinion on Drug Safety|June 7, 2018
Cardiovascular outcomes of patients with rheumatoid arthritis prescribed disease modifying anti-rheumatic drugs: a reviewAlessandro Giollo, Lesley-Anne Bissell, Maya H Buch
Autoimmunity Reviews|November 1, 2011
To switch or not to switch after a poor response to a TNFα blocker? It is not only a matter of ACR20 OR ACR50Maya H Buch, Andrea Rubbert-Roth, Gianfranco Ferraccioli
Acta Ophthalmologica Scandinavica|August 27, 1999
Pachometry before and after vitrectomy with silicone oil injectionH Buch, N V Nielsen, J U Prause
Nature Reviews. Rheumatology|June 2, 2017
Biologics registers in RA: methodological aspects, current role and future applicationsElena Nikiphorou, Maya H Buch, Kimme L Hyrich
Arthritis Research & Therapy|November 26, 2008
Abatacept in the treatment of rheumatoid arthritisMaya H Buch, Edward M Vital, Paul Emery
Therapeutic Advances in Cardiovascular Disease|February 10, 2011
Antiplatelet therapy and vascular disease: an updateMamta H Buch, Bernard D Prendergast, Robert F Storey
Nature Reviews. Rheumatology|February 6, 2013
Creative trial design in RA: optimizing patient outcomesMaya H Buch, Sue Pavitt, Mahesh Parmar, et al.
Pageof 21